| |
| |
| Veeda Oncology is a global oncology company
and a member of the
Veeda CR family of
companies. While Veeda Oncology is a growing
company, our management team has over 20 years
of clinical experience in the oncology field
with facilities located in the US, Europe and
India. These strategic locations provide a
tremendous feet-on-the-ground perspective to
best serve our sponsors. |
| |
| Our expertise has evolved from strong working
relationships with pharmaceutical, as well as
biotech, companies. Previous clients range from
very large established companies to start-up
biotechnology companies. Our mission is to
provide outstanding oncology expertise that our
clients require and expect to facilitate
successful Phase I to Phase IV global programs. |
| |
| A basic overview of our operational
capabilities and characteristics include. |
| |
- Oncology expertise to provide support from
the creation of the clinical development plan to
the submission and defense of the regulatory
application.
- All systems that Veeda Oncology utilizes are
recognized as industry standards.
- ClinTrials™ for our clinical data
management system
- Phase Forward (InForm names™) for electronic data capture (EDC)
- TrialWorks® by ClinPhone for the
clinical trial management system
- SAS® Enterprise Business Intelligence
for our Ad hoc reporting requirements
- Microsoft Office Project Server for
tracking of deliverables
- A strong history of positive site
relationships that enables us to improve time to
site opening and appropriate site selection.
- Unique dedicated relationships with several
large oncology hospitals in India that treat
over 10,000 new oncology patients each year.
These exclusive relationships significantly
improve access to oncology patients with a
reasonable cost structure, so that we meet
accrual targets.
- The Veeda Oncology Network is composed of
US-based community oncology practices of varying
sizes, all of which are fully capable of
conducting Phase II- IV oncology clinical
trials. In addition, select practices have Phase
I experience and capabilities. Sites are
assessed annually for site research
qualification and Good Clinical Practice (GCP)
compliance. In addition, an in-depth Site
Profile is maintained in real time
|
| |
| |
